CN Stock MarketDetailed Quotes

301033 Medprin Regenerative Medical Technologies

Watchlist
  • 39.11
  • +0.33+0.85%
Market Closed Jun 28 15:00 CST
2.58BMarket Cap53.80P/E (TTM)

Medprin Regenerative Medical Technologies Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
28.59%57.21M
18.24%230.87M
4.69%145.78M
-9.80%85.72M
19.35%44.49M
26.96%195.25M
34.75%139.25M
38.24%95.02M
14.63%37.27M
24.51%153.79M
Operating revenue
28.59%57.21M
18.24%230.87M
4.69%145.78M
-9.80%85.72M
19.35%44.49M
26.96%195.25M
34.75%139.25M
38.24%95.02M
14.63%37.27M
24.51%153.79M
Other operating revenue
----
1,308.63%3.33M
----
--1.24M
----
--236.57K
----
--0
----
--0
Total operating cost
15.86%43.04M
11.95%189.59M
4.31%119.87M
-4.58%74.79M
15.16%37.15M
33.03%169.36M
47.35%114.92M
57.11%78.37M
37.69%32.25M
30.40%127.31M
Operating cost
23.73%10.7M
33.03%41.54M
34.92%27.67M
24.75%17.29M
44.03%8.65M
15.28%31.23M
9.75%20.51M
8.14%13.86M
-4.86%6.01M
32.76%27.09M
Operating tax surcharges
19.42%1.16M
123.75%4.57M
145.54%3.05M
220.05%1.98M
1,237.64%967.22K
211.09%2.04M
119.97%1.24M
69.31%617.91K
-52.42%72.31K
-41.31%656.2K
Operating expense
1.91%12.23M
-12.13%61.75M
-22.37%38.39M
-33.38%23.55M
-8.23%12.01M
44.61%70.27M
69.24%49.45M
86.65%35.35M
55.58%13.08M
21.11%48.59M
Administration expense
43.57%13.51M
54.18%54.42M
42.36%32.95M
32.04%19.9M
29.47%9.41M
44.61%35.3M
54.47%23.15M
62.46%15.07M
54.63%7.27M
25.15%24.41M
Financial expense
-65.10%158.09K
630.85%531.59K
142.81%253.17K
191.19%48.41K
117.78%453.01K
-114.67%-100.14K
-226.76%-591.31K
-111.37%-53.08K
-22.93%208.01K
238.78%682.41K
-Interest expense (Financial expense)
-11.70%508.27K
23.80%2.21M
157.60%1.67M
441.83%1.12M
436.00%575.62K
260.58%1.78M
54.35%649.97K
-19.14%207.57K
-15.60%107.39K
--494.52K
-Interest Income (Financial expense)
5.21%-469.69K
-90.35%-1.88M
-177.23%-1.41M
-610.99%-952.21K
-838.50%-495.53K
-151.02%-989.7K
-90.69%-509.01K
-54.86%-133.93K
-47.45%-52.8K
-162.86%-394.28K
Research and development
-6.77%5.28M
-12.53%26.78M
-17.03%17.56M
-11.16%12.02M
0.74%5.66M
18.31%30.61M
50.41%21.16M
68.64%13.53M
56.80%5.62M
58.94%25.88M
Credit Impairment Loss
77.60%-9.26K
-330.09%-36.56K
-210.77%-51.1K
52.28%-22.87K
-210.69%-41.35K
-132.18%-8.5K
-129.49%-16.44K
-190.48%-47.91K
-237.27%-13.31K
155.65%26.42K
Asset Impairment Loss
116.18%1.31K
1.31%-32.61K
-17.48%-39.01K
-182.26%-15.91K
---8.08K
83.61%-33.04K
-51.93%-33.21K
74.10%-5.64K
----
51.45%-201.64K
Other net revenue
185.33%4.56M
-54.75%6.99M
-53.88%4.48M
-58.19%3.17M
-52.89%1.6M
-10.35%15.45M
5.77%9.72M
33.28%7.57M
4.16%3.39M
25.97%17.23M
Fair value change income
131.55%234.42K
115.58%125.72K
77.89%-145.88K
384.15%409.09K
-45.94%101.24K
-182.39%-807.09K
-210.80%-659.83K
-124.37%-143.97K
855.61%187.26K
144.32%979.61K
Invest income
0.11%850.06K
-59.46%3.56M
-58.76%2.92M
-66.78%1.62M
-61.05%849.09K
44.21%8.79M
83.54%7.08M
120.02%4.89M
52.15%2.18M
24.63%6.1M
Asset deal income
----
----
----
----
----
1,560.57%166.51K
-11,027.02%-933.8K
----
----
-87.13%10.03K
Other revenue
400.08%3.48M
-54.08%3.37M
-57.98%1.8M
-59.31%1.17M
-32.78%695.66K
-28.89%7.34M
-8.78%4.28M
1.48%2.88M
-44.13%1.03M
17.67%10.32M
Operating profit
109.53%18.73M
16.74%48.27M
-10.75%30.39M
-41.81%14.1M
6.31%8.94M
-5.41%41.35M
-1.41%34.05M
-1.26%24.22M
-31.89%8.41M
10.49%43.71M
Add:Non operating Income
56.23%10.75K
581.43%267.76K
-67.85%12.07K
-37.72%8.07K
2,099.17%6.88K
-99.51%39.29K
-98.75%37.53K
568.96%12.95K
76.71%312.76
95.82%8.01M
Less:Non operating expense
36.44%13.17K
-63.95%513.36K
210.91%550.4K
197.53%221.5K
-81.66%9.65K
1,010.24%1.42M
89.47%177.03K
10.57%74.45K
76.32%52.63K
-80.29%128.25K
Total profit
109.57%18.72M
20.17%48.02M
-11.97%29.85M
-42.54%13.88M
6.94%8.93M
-22.55%39.96M
-9.44%33.91M
-1.25%24.16M
-32.15%8.35M
19.99%51.6M
Less:Income tax cost
238.05%3.78M
68.99%7.14M
9.81%4.43M
-35.64%1.99M
-7.24%1.12M
-38.89%4.23M
-25.53%4.03M
-13.03%3.09M
-37.38%1.2M
12.53%6.92M
Net profit
91.19%14.94M
14.39%40.88M
-14.90%25.42M
-43.56%11.89M
9.33%7.82M
-20.02%35.73M
-6.72%29.88M
0.76%21.07M
-31.18%7.15M
21.23%44.68M
Net profit from continuing operation
91.19%14.94M
14.39%40.88M
-14.90%25.42M
-43.56%11.89M
9.33%7.82M
-20.02%35.73M
-6.72%29.88M
0.76%21.07M
-31.18%7.15M
21.23%44.68M
Less:Minority Profit
----
----
----
----
----
-382.05%-156.87K
-819.74%-156.87K
-1,129.04%-157.48K
-29.09%-9.48K
70.66%-32.54K
Net profit of parent company owners
91.19%14.94M
13.89%40.88M
-15.35%25.42M
-43.98%11.89M
9.19%7.82M
-19.73%35.89M
-6.28%30.03M
1.45%21.23M
-31.14%7.16M
20.95%44.71M
Earning per share
Basic earning per share
91.67%0.23
14.81%0.62
-15.56%0.38
-43.75%0.18
9.09%0.12
-31.65%0.54
-25.00%0.45
-23.81%0.32
-47.62%0.11
5.33%0.79
Diluted earning per share
91.67%0.23
14.81%0.62
-15.56%0.38
-43.75%0.18
9.09%0.12
-31.65%0.54
-25.00%0.45
-23.81%0.32
-47.62%0.11
5.33%0.79
Other composite income
-86.87%136.48K
1.04M
0
Other composite income of parent company owners
----
-86.87%136.48K
----
----
----
--1.04M
----
----
----
--0
Total composite income
91.19%14.94M
11.53%41.01M
-14.90%25.42M
-43.56%11.89M
9.33%7.82M
-17.70%36.77M
-6.72%29.88M
0.76%21.07M
-31.18%7.15M
21.23%44.68M
Total composite income of parent company owners
91.19%14.94M
11.06%41.01M
-15.35%25.42M
-43.98%11.89M
9.19%7.82M
-17.41%36.93M
-6.28%30.03M
1.45%21.23M
-31.14%7.16M
20.95%44.71M
Total composite income of minority owners
----
----
----
----
----
-382.05%-156.87K
-819.74%-156.87K
-1,129.04%-157.48K
-29.09%-9.48K
70.66%-32.54K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 28.59%57.21M18.24%230.87M4.69%145.78M-9.80%85.72M19.35%44.49M26.96%195.25M34.75%139.25M38.24%95.02M14.63%37.27M24.51%153.79M
Operating revenue 28.59%57.21M18.24%230.87M4.69%145.78M-9.80%85.72M19.35%44.49M26.96%195.25M34.75%139.25M38.24%95.02M14.63%37.27M24.51%153.79M
Other operating revenue ----1,308.63%3.33M------1.24M------236.57K------0------0
Total operating cost 15.86%43.04M11.95%189.59M4.31%119.87M-4.58%74.79M15.16%37.15M33.03%169.36M47.35%114.92M57.11%78.37M37.69%32.25M30.40%127.31M
Operating cost 23.73%10.7M33.03%41.54M34.92%27.67M24.75%17.29M44.03%8.65M15.28%31.23M9.75%20.51M8.14%13.86M-4.86%6.01M32.76%27.09M
Operating tax surcharges 19.42%1.16M123.75%4.57M145.54%3.05M220.05%1.98M1,237.64%967.22K211.09%2.04M119.97%1.24M69.31%617.91K-52.42%72.31K-41.31%656.2K
Operating expense 1.91%12.23M-12.13%61.75M-22.37%38.39M-33.38%23.55M-8.23%12.01M44.61%70.27M69.24%49.45M86.65%35.35M55.58%13.08M21.11%48.59M
Administration expense 43.57%13.51M54.18%54.42M42.36%32.95M32.04%19.9M29.47%9.41M44.61%35.3M54.47%23.15M62.46%15.07M54.63%7.27M25.15%24.41M
Financial expense -65.10%158.09K630.85%531.59K142.81%253.17K191.19%48.41K117.78%453.01K-114.67%-100.14K-226.76%-591.31K-111.37%-53.08K-22.93%208.01K238.78%682.41K
-Interest expense (Financial expense) -11.70%508.27K23.80%2.21M157.60%1.67M441.83%1.12M436.00%575.62K260.58%1.78M54.35%649.97K-19.14%207.57K-15.60%107.39K--494.52K
-Interest Income (Financial expense) 5.21%-469.69K-90.35%-1.88M-177.23%-1.41M-610.99%-952.21K-838.50%-495.53K-151.02%-989.7K-90.69%-509.01K-54.86%-133.93K-47.45%-52.8K-162.86%-394.28K
Research and development -6.77%5.28M-12.53%26.78M-17.03%17.56M-11.16%12.02M0.74%5.66M18.31%30.61M50.41%21.16M68.64%13.53M56.80%5.62M58.94%25.88M
Credit Impairment Loss 77.60%-9.26K-330.09%-36.56K-210.77%-51.1K52.28%-22.87K-210.69%-41.35K-132.18%-8.5K-129.49%-16.44K-190.48%-47.91K-237.27%-13.31K155.65%26.42K
Asset Impairment Loss 116.18%1.31K1.31%-32.61K-17.48%-39.01K-182.26%-15.91K---8.08K83.61%-33.04K-51.93%-33.21K74.10%-5.64K----51.45%-201.64K
Other net revenue 185.33%4.56M-54.75%6.99M-53.88%4.48M-58.19%3.17M-52.89%1.6M-10.35%15.45M5.77%9.72M33.28%7.57M4.16%3.39M25.97%17.23M
Fair value change income 131.55%234.42K115.58%125.72K77.89%-145.88K384.15%409.09K-45.94%101.24K-182.39%-807.09K-210.80%-659.83K-124.37%-143.97K855.61%187.26K144.32%979.61K
Invest income 0.11%850.06K-59.46%3.56M-58.76%2.92M-66.78%1.62M-61.05%849.09K44.21%8.79M83.54%7.08M120.02%4.89M52.15%2.18M24.63%6.1M
Asset deal income --------------------1,560.57%166.51K-11,027.02%-933.8K---------87.13%10.03K
Other revenue 400.08%3.48M-54.08%3.37M-57.98%1.8M-59.31%1.17M-32.78%695.66K-28.89%7.34M-8.78%4.28M1.48%2.88M-44.13%1.03M17.67%10.32M
Operating profit 109.53%18.73M16.74%48.27M-10.75%30.39M-41.81%14.1M6.31%8.94M-5.41%41.35M-1.41%34.05M-1.26%24.22M-31.89%8.41M10.49%43.71M
Add:Non operating Income 56.23%10.75K581.43%267.76K-67.85%12.07K-37.72%8.07K2,099.17%6.88K-99.51%39.29K-98.75%37.53K568.96%12.95K76.71%312.7695.82%8.01M
Less:Non operating expense 36.44%13.17K-63.95%513.36K210.91%550.4K197.53%221.5K-81.66%9.65K1,010.24%1.42M89.47%177.03K10.57%74.45K76.32%52.63K-80.29%128.25K
Total profit 109.57%18.72M20.17%48.02M-11.97%29.85M-42.54%13.88M6.94%8.93M-22.55%39.96M-9.44%33.91M-1.25%24.16M-32.15%8.35M19.99%51.6M
Less:Income tax cost 238.05%3.78M68.99%7.14M9.81%4.43M-35.64%1.99M-7.24%1.12M-38.89%4.23M-25.53%4.03M-13.03%3.09M-37.38%1.2M12.53%6.92M
Net profit 91.19%14.94M14.39%40.88M-14.90%25.42M-43.56%11.89M9.33%7.82M-20.02%35.73M-6.72%29.88M0.76%21.07M-31.18%7.15M21.23%44.68M
Net profit from continuing operation 91.19%14.94M14.39%40.88M-14.90%25.42M-43.56%11.89M9.33%7.82M-20.02%35.73M-6.72%29.88M0.76%21.07M-31.18%7.15M21.23%44.68M
Less:Minority Profit ---------------------382.05%-156.87K-819.74%-156.87K-1,129.04%-157.48K-29.09%-9.48K70.66%-32.54K
Net profit of parent company owners 91.19%14.94M13.89%40.88M-15.35%25.42M-43.98%11.89M9.19%7.82M-19.73%35.89M-6.28%30.03M1.45%21.23M-31.14%7.16M20.95%44.71M
Earning per share
Basic earning per share 91.67%0.2314.81%0.62-15.56%0.38-43.75%0.189.09%0.12-31.65%0.54-25.00%0.45-23.81%0.32-47.62%0.115.33%0.79
Diluted earning per share 91.67%0.2314.81%0.62-15.56%0.38-43.75%0.189.09%0.12-31.65%0.54-25.00%0.45-23.81%0.32-47.62%0.115.33%0.79
Other composite income -86.87%136.48K1.04M0
Other composite income of parent company owners -----86.87%136.48K--------------1.04M--------------0
Total composite income 91.19%14.94M11.53%41.01M-14.90%25.42M-43.56%11.89M9.33%7.82M-17.70%36.77M-6.72%29.88M0.76%21.07M-31.18%7.15M21.23%44.68M
Total composite income of parent company owners 91.19%14.94M11.06%41.01M-15.35%25.42M-43.98%11.89M9.19%7.82M-17.41%36.93M-6.28%30.03M1.45%21.23M-31.14%7.16M20.95%44.71M
Total composite income of minority owners ---------------------382.05%-156.87K-819.74%-156.87K-1,129.04%-157.48K-29.09%-9.48K70.66%-32.54K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg